{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:01:47Z","timestamp":1794916907919,"version":"4.9.1"},"reference-count":72,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuklearmedizin"],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Version 5 der Leitlinie zur Radioiodtherapie bei benignen Schilddr\u00fcsenerkrankungen ist ein Update der Version 4, die im Jahr 2007 durch die Deutsche Gesellschaft f\u00fcr Nuklearmedizin (DGN) in Abstimmung mit der Deutschen Gesellschaft f\u00fcr Endokrinologie (DGE, Sektion Schilddr\u00fcse) und der Deutschen Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie (DGAV) publiziert worden war. Die Leitlinie ist mit den Empfehlungen der European Association of Nuclear Medicine (EANM) harmonisiert worden. Nach der \u201eRichtlinie Strahlenschutz in der Medizin\u201c ist die \u201erechtfertigende Indikation\u201c zur Radioiodtherapie durch einen fachkundigen Arzt (\u201eFachkunde in der Therapie mit offenen radioaktiven Stoffen\u201c) zu stellen. Daher werden Indikationen zur Radioiodtherapie und alternative Behandlungsm\u00f6glichkeiten in dieser Leitlinie diskutiert. Die Leitlinie wurde von einer repr\u00e4sentativen Expertengruppe im informellen Konsens verabschiedet und entspricht damit einer Verfahrensanweisung der ersten Stufe (S1) nach den Kriterien der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF).<\/jats:p>","DOI":"10.3413\/nukmed-0823-16-04","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T10:07:46Z","timestamp":1481018866000},"page":"213-220","source":"Crossref","is-referenced-by-count":29,"title":["Radioiodtherapie bei benignen Schilddr\u00fcsenerkrankungen (Version 5)*"],"prefix":"10.3413","volume":"55","author":[{"given":"Frank","family":"Gr\u00fcnwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Verburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Luster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Dietlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"10.3413\/Nukmed-0823-16-04-1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32832b5ccc"},{"key":"10.3413\/Nukmed-0823-16-04-2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0417"},{"key":"10.3413\/Nukmed-0823-16-04-3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801083380201"},{"key":"10.3413\/Nukmed-0823-16-04-4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0666"},{"key":"10.3413\/Nukmed-0823-16-04-5","doi-asserted-by":"crossref","unstructured":"Bonnema SJ, Bennedbaek FN, Veje A et al. Propylthiouracil before I-131 therapy of hyperthyroid diseases; effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab 2004; 89: 4439-4444","DOI":"10.1210\/jc.2004-0247"},{"key":"10.3413\/Nukmed-0823-16-04-6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0501"},{"key":"10.3413\/Nukmed-0823-16-04-7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1888-7"},{"key":"10.3413\/Nukmed-0823-16-04-8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02218.x"},{"key":"10.3413\/Nukmed-0823-16-04-9","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-0992-2"},{"key":"10.3413\/Nukmed-0823-16-04-10","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3283134d4d"},{"key":"10.3413\/Nukmed-0823-16-04-11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0348"},{"key":"10.3413\/Nukmed-0823-16-04-12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1372111"},{"key":"10.3413\/Nukmed-0823-16-04-13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0110"},{"key":"10.3413\/Nukmed-0823-16-04-14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-924321"},{"key":"10.3413\/Nukmed-0823-16-04-15","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie. Operative Therapie benigner Schilddr\u00fcsenerkrankungen. AWMF-Leitlinien-Register Nr. 003\/002, letzte Aktualisierung 2010; www.awmf.de\/leitlinien\/detail\/II\/003-002.html"},{"key":"10.3413\/Nukmed-0823-16-04-16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623928","volume":"45","author":"Dietlein","year":"2006","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-17","unstructured":"Dietlein M, Eschner W, Lassmann M et al. DGN-Handlungsempfehlung (S1-Leitlinie): Radioiodtest (Version 4). Stand 10\/2014 - AWMF-Registernummer: 031-012"},{"key":"10.3413\/Nukmed-0823-16-04-18","unstructured":"Dietlein M, Eschner W, Lassmann H et al. DGN-Handlungsempfehlung (S1-Leitlinie): Schilddr\u00fcsenszintigraphie (Version 4). Stand 10\/2014 - AWMF-Registernummer: 031-011"},{"issue":"Suppl V","key":"10.3413\/Nukmed-0823-16-04-19","first-page":"45","volume":"98","author":"Dralle","year":"2004","journal-title":"Z \u00c4rztl Fortbild Qual Gesundh"},{"key":"10.3413\/Nukmed-0823-16-04-20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0038-1632206","volume":"38","author":"Dunkelmann","year":"1999","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1519-8"},{"key":"10.3413\/Nukmed-0823-16-04-22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1625320","volume":"44","author":"Dunkelmann","year":"2005","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0234-z"},{"key":"10.3413\/Nukmed-0823-16-04-24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2813"},{"key":"10.3413\/Nukmed-0823-16-04-25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.060152"},{"key":"10.3413\/Nukmed-0823-16-04-26","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0370"},{"key":"10.3413\/Nukmed-0823-16-04-27","first-page":"103","volume":"23","author":"Holm","year":"1982","journal-title":"J Nucl Med"},{"key":"10.3413\/Nukmed-0823-16-04-28","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. Release of patients after therapy with unsealed radionuclides. Ann ICRP. 2004; 34: 1-79. Erratum in: Ann ICRP 2004; 34: 281. Ann ICRP 2006; 36: 77","DOI":"10.1016\/j.icrp.2006.07.002"},{"key":"10.3413\/Nukmed-0823-16-04-29","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01924"},{"key":"10.3413\/Nukmed-0823-16-04-30","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.2106.ed3"},{"key":"10.3413\/Nukmed-0823-16-04-31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04204.x"},{"key":"10.3413\/Nukmed-0823-16-04-32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3413\/nukmed-0087","volume":"47","author":"Kobe","year":"2008","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3413\/nukmed-0145","volume":"47","author":"Kobe","year":"2008","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-34","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328333d303"},{"key":"10.3413\/Nukmed-0823-16-04-35","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K06-057"},{"key":"10.3413\/Nukmed-0823-16-04-36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2130"},{"key":"10.3413\/Nukmed-0823-16-04-37","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1363193"},{"key":"10.3413\/Nukmed-0823-16-04-38","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12654"},{"key":"10.3413\/Nukmed-0823-16-04-39","doi-asserted-by":"crossref","unstructured":"Ma C, Kuang A, Xie J, Liu GJ. Radioiodine for pediatric Graves\u2019 disease. John Wiley & Sons, Ltd, 2009. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006294.","DOI":"10.1002\/14651858.CD006294.pub2"},{"key":"10.3413\/Nukmed-0823-16-04-40","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.14.1476"},{"key":"10.3413\/Nukmed-0823-16-04-41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021554"},{"key":"10.3413\/Nukmed-0823-16-04-42","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2013.2552"},{"key":"10.3413\/Nukmed-0823-16-04-43","doi-asserted-by":"publisher","DOI":"10.4103\/1450-1147.98731"},{"key":"10.3413\/Nukmed-0823-16-04-44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0507"},{"key":"10.3413\/Nukmed-0823-16-04-45","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0722-0"},{"key":"10.3413\/Nukmed-0823-16-04-46","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0877-3"},{"key":"10.3413\/Nukmed-0823-16-04-47","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-0051-9"},{"key":"10.3413\/Nukmed-0823-16-04-48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1239"},{"key":"10.3413\/Nukmed-0823-16-04-49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.4.745"},{"key":"10.3413\/Nukmed-0823-16-04-50","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.14424"},{"key":"10.3413\/Nukmed-0823-16-04-51","doi-asserted-by":"publisher","DOI":"10.1089\/1050725041517093"},{"key":"10.3413\/Nukmed-0823-16-04-52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1625598","volume":"43","author":"Schicha","year":"2004","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-53","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.281"},{"key":"10.3413\/Nukmed-0823-16-04-54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7895"},{"key":"10.3413\/Nukmed-0823-16-04-55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4184"},{"key":"10.3413\/Nukmed-0823-16-04-56","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0218"},{"key":"10.3413\/Nukmed-0823-16-04-57","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.105148"},{"key":"10.3413\/Nukmed-0823-16-04-58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01918.x"},{"key":"10.3413\/Nukmed-0823-16-04-59","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0258"},{"key":"10.3413\/Nukmed-0823-16-04-60","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1536-8"},{"key":"10.3413\/Nukmed-0823-16-04-61","unstructured":"Strahlenschutz in der Medizin - Richtlinie zur Verordnung \u00fcber den Schutz vor Sch\u00e4den durch ionisierende Strahlen (Strahlenschutzverordnung - StrlSchV). Gemeinsames Ministerialblatt 2011, S. 867"},{"key":"10.3413\/Nukmed-0823-16-04-62","unstructured":"Strahlenschutzkommission (SSK) des Bundesministeriums f\u00fcr Umwelt, Naturschutz und Reaktorsicherheit. Ambulante, fraktionierte Radioiodtherapie. Empfehlung der Strahlenschutzkommission vom 22.\/23. Februar 1996. Bundesanzeiger Nr. 132 (18.7.1996)"},{"key":"10.3413\/Nukmed-0823-16-04-63","unstructured":"Strahlenschutzkommission (SSK) des Bundesministeriums f\u00fcr Umwelt, Naturschutz und Reaktorsicherheit. Strahlenschutzgrunds\u00e4tze f\u00fcr die Radioiodtherapie. Empfehlung der Strahlenschutzkommission vom 5.\/6. Dezember 1996. Bundesanzeiger Nr. 68 (11.4.1997)"},{"key":"10.3413\/Nukmed-0823-16-04-64","unstructured":"Strahlenschutzkommission (SSK) des Bundesministeriums f\u00fcr Umwelt, Naturschutz und Reaktorsicherheit. Nachsorge f\u00fcr Patienten nach Strahlenbehandlung. Empfehlung der Strahlenschutzkommission vom 11.\/12. Februar 1998. Bundesanzeiger Nr. 114 (6.8.1998)"},{"key":"10.3413\/Nukmed-0823-16-04-65","unstructured":"Strahlenschutzverordnung. Textausgabe mit einer erl\u00e4uternden Einf\u00fchrung von Hans-Michael Veith. 8. Aufl. K\u00f6ln: Bundesanzeiger-Verlag 2010"},{"key":"10.3413\/Nukmed-0823-16-04-66","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0100"},{"key":"10.3413\/Nukmed-0823-16-04-67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0506"},{"key":"10.3413\/Nukmed-0823-16-04-68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1623930","volume":"45","author":"Vogt","year":"2006","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0823-16-04-69","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0092-8"},{"key":"10.3413\/Nukmed-0823-16-04-70","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.3.7244"},{"key":"10.3413\/Nukmed-0823-16-04-71","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182816717"},{"key":"10.3413\/Nukmed-0823-16-04-72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1962"}],"container-title":["Nuklearmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.3413\/Nukmed-0823-16-04.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T08:04:11Z","timestamp":1568621051000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.3413\/Nukmed-0823-16-04"}},"subtitle":["DGN-Handlungsempfehlung (S1-Leitlinie)"],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":72,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2018,1,9]]},"published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.3413\/nukmed-0823-16-04","relation":{},"ISSN":["0029-5566","2567-6407"],"issn-type":[{"value":"0029-5566","type":"print"},{"value":"2567-6407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}